repurposed microfilament therapeutics (Erza)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namerepurposed microfilament therapeutics (Erza)
Drug Alias Namediabetic complication therapeutics (Ezra)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEZRA Innovations LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEZRA Innovations LLC
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A